PIMA542030
Varlilumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA542030-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA542030 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Varlilumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
CDX-1127
Immunogen
Human CD27/TNFRSF7
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
2 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG1 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Varlilumab has been used in trials studying the treatment of MELANOMA, Skin Ulcer, Burkett's Lymphoma, Mantle cell lymphoma, and Any T-cell Malignancy, among others.
Compare Similar Items
Show Difference
Antigen: Varlilumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: CDX-1127
Immunogen: Human CD27/TNFRSF7
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 2 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Varlilumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
CDX-1127
Immunogen:
Human CD27/TNFRSF7
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
2 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Pasotuxizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: BAY 2010112; BITE MT112; MT-112
Immunogen: Human CD3E/FOLH1
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 0.65 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Metal-chelate chromatography
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: scFv κ, scFv λ
Antigen:
Pasotuxizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
BAY 2010112; BITE MT112; MT-112
Immunogen:
Human CD3E/FOLH1
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
0.65 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Metal-chelate chromatography
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
scFv κ, scFv λ
Antigen: Lulizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: BMS-931699
Immunogen: Human CD28
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA
Concentration: 0.51 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Metal-chelate chromatography
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: __
Antigen:
Lulizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
BMS-931699
Immunogen:
Human CD28
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA
Concentration:
0.51 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Metal-chelate chromatography
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
__
Antigen: Vanucizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: RG7221; RG-7221; RO5520985
Immunogen: Human, ANGPT2/VEGFA
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: __
Antigen:
Vanucizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
RG7221; RG-7221; RO5520985
Immunogen:
Human, ANGPT2/VEGFA
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
__